Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1866596Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pediatrics
NIH Funding · FY2025
Linked Award Amount
$1.7M
Full award amounts, FY2025
Award Records
6
Records listing this PI
Award-Linked Rank
#8,402
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Julie D Saba as a PI. Multi-PI records show the full award amount for context.
- 5R01HD113778-02R01Characterizing the natural history of sphingosine phosphate lyase insufficiency syndrome (SPLIS): a fundamental step in the development of a targeted cure for this novel atypical sphingolipidosis$682.2Kaward amount
- 5R61HL171786-02R61Adeno-associated virus-mediated SGPL1 gene therapy as a first-in-class treatment for idiopathic pulmonary fibrosis that acts by reducing sphingosine-1-phosphate and downstream profibrotic signaling$565.3Kaward amount
- 1R21OD037868-01R21Characterizing a novel mouse model linking sphingolipid metabolism to multi-organ fibrosis$246Kaward amount
- 3R01HD113778-02S1R01Characterizing the natural history of sphingosine phosphate lyase insufficiency syndrome (SPLIS): a fundamental step in the development of a targeted cure for this novel atypical sphingolipidosis$105Kaward amount
- 3R61HL171786-01S1R61Adeno-associated virus-mediated SGPL1 gene therapy as a first-in-class treatment for idiopathic pulmonary fibrosis that acts by reducing sphingosine-1-phosphate and downstream profibrotic signaling$62.8Kaward amount
- 3R01HD113778-01S1R01Characterizing the natural history of sphingosine phosphate lyase insufficiency syndrome (SPLIS): a fundamental step in the development of a targeted cure for this novel atypical sphingolipidosis$54.9Kaward amount
Award organization
Organizations that administered FY2025 awards listing Julie D Saba as a PI.
FY2025 award administered by University of California, San Francisco (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of California, San Francisco
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #6968
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder